CNS effects of sumatriptan and rizatriptan

Cephalalgia

Volumn 24, Issue 1, 2004, Pages 78-79

  Silberstein, S D ^a   Diener, H C ^b   McCarroll, K A ^c   Lines, C R ^c   Van Der Post, J ^d  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

^d CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; NERVE PROTEIN; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; TEMAZEPAM; TRIAZOLE DERIVATIVE;

ADULT; AFFECT; BODY EQUILIBRIUM; BRAIN; COGNITION; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG FORMULATION; ELECTROENCEPHALOGRAPHY; ENCAPSULATION; EYE MOVEMENT; FEMALE; HEADACHE; HUMAN; IATROGENIC DISEASE; LETTER; MIGRAINE; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; REACTION TIME; RECOGNITION;

ADULT; AFFECT; BRAIN; COGNITION; CROSS-OVER STUDIES; DIZZINESS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EYE MOVEMENTS; FEMALE; HEADACHE; HUMANS; HYPNOTICS AND SEDATIVES; MUSCULOSKELETAL EQUILIBRIUM; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; RECOGNITION (PSYCHOLOGY); SEROTONIN AGONISTS; SUMATRIPTAN; TEMAZEPAM; TRIAZOLES; TRYPTAMINES;

EID: 0347634398     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.t01-2-00610.x     Document Type: Letter

References (0)